|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$13.09 0.00 (0.00%) as of 4:30 Wed 4/16
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
76,374,000 |
| Market
Cap: |
999.74(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.78 - $13.09 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Paragon 28 is a medical device company focused on the foot and ankle orthopedic market. Co.'s orthopedic solutions, procedural approaches and instrumentation cover a range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity or flatfoot charcot foot and orthobiologics. To treat these conditions, Co. provides a portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. Co. has developed a portfolio of foot and ankle surgical systems including plates, screws, nails, joint and bone replacements, orthobiologics, and other implantation instruments and disposables.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
58,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$514,781 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
2,575,557 |
3,082,098 |
3,082,098 |
| Total Sell Value |
$0 |
$33,344,549 |
$38,521,435 |
$38,521,435 |
| Total People Sold |
0 |
1 |
2 |
2 |
| Total Sell Transactions |
0 |
8 |
20 |
20 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Scanlon Meghan |
|
– • – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,113) |
0 |
|
- |
|
| Johnson B Kristine |
|
– • – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(47,347) |
0 |
|
- |
|
| Hill Andrew James |
EVP of Research & Development |
• – – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(126,397) |
0 |
|
- |
|
| Chahine Chadi |
See Remarks |
• – – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(520,657) |
0 |
|
- |
|
| Blackford Quentin S. |
|
– • – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,554) |
0 |
|
- |
|
| Wright Kristina |
|
– • – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(32,118) |
0 |
|
- |
|
| Mccormack Robert S |
See Remarks |
• – – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(203,134) |
0 |
|
- |
|
| Dacosta Albert |
See Remarks |
• • • |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,439,110) |
0 |
|
- |
|
| Dacosta Albert |
See Remarks |
• • • |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,314,614) |
0 |
|
- |
|
| Schnettler Thomas P |
|
– • – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(45,035) |
0 |
|
- |
|
| Grunwald Alf |
|
– • – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(51,935) |
0 |
|
- |
|
| Jarboe Matthew |
Chief Commercial Officer |
• – – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(575,320) |
0 |
|
- |
|
| Oesterle Stephen N |
|
– • – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,216) |
0 |
|
- |
|
| Demski David M |
|
– • – |
2025-04-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(74,307) |
0 |
|
- |
|
| Hill Andrew James |
EVP of Research & Development |
• • – |
2025-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
49,884 |
126,397 |
|
- |
|
| Mccormack Robert S |
See Remarks |
• • – |
2025-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
90,867 |
203,134 |
|
- |
|
| Jarboe Matthew |
Chief Commercial Officer |
• • – |
2025-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
117,344 |
575,320 |
|
- |
|
| Dacosta Albert |
See Remarks |
• • • |
2025-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
337,682 |
1,314,614 |
|
- |
|
| Chahine Chadi |
See Remarks |
• • – |
2025-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
145,817 |
520,657 |
|
- |
|
| Dacosta Albert |
See Remarks |
• • • |
2025-03-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,061,702 |
2,061,702 |
|
- |
|
| Dacosta Albert |
See Remarks |
• • • |
2025-03-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,061,702 |
3,277,408 |
|
- |
|
| Mvm Partners, Llc |
10% Owner |
– – • |
2025-03-13 |
4 |
S |
$13.04 |
$13,618,129 |
I/I |
(1,044,295) |
7,810,588 |
|
-1% |
|
| Dacosta Albert |
See Remarks |
• • • |
2025-03-10 |
4 |
D |
$13.01 |
$237,537 |
D/D |
(18,258) |
976,932 |
|
- |
|
| Jarboe Matthew |
Chief Commercial Officer |
• • – |
2025-03-10 |
4 |
D |
$13.01 |
$139,623 |
D/D |
(10,732) |
457,976 |
|
- |
|
| Mccormack Robert S |
See Remarks |
• • – |
2025-03-10 |
4 |
D |
$13.01 |
$106,227 |
D/D |
(8,165) |
112,267 |
|
- |
|
212 Records found
|
|
Page 1 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
